packageSelumetinib
selumetinib
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Selumetinib is a MEK inhibitor anticancer drug used to treat neurofibromatosis 1 and has been studied for low-grade serous carcinoma. It is authorised in the European Union for neurofibromatosis 1 and is also under investigation for other uses.
Summary written by glm-5.3-flash from Wikidata Q7448840 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | selumetinib |
| ATC codes: | L01EE04 |
| DrugBank: | DB11689 |
| PubChem CID: | 10127622 |
| ChEBI: | 90227 |
| Wikidata: | Q7448840 |
| formula: | C17H15BrClFN4O3 |
| molar mass: | 457.684 g/mol (PubChem CID 10127622) |
| logP: | 3.6 (Drugs.Common 25.09, not verified) |
Metabolites
NDesmethylSelumetinib | N-desmethyl-selumetinib | 443.657 g/mol (pubchem) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |
Contents
| Name | Description |
|---|---|
| metabolite: N-desmethyl-selumetinib |